A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs) is out – and will make uncomfortable reading for the pharma supply chain middlemen.

Al Roberts and Travis Hale, the owners of Remington Drug Company in Remington, Va., hosted Andrew Ferguson, chair of the ...

Last year, the Federal Trade Commission (FTC) caused consternation among pharmacy benefit managers (PBMs ... highly critical report. The new document focuses on the influence of PBMs over the ...

The three largest pharmacy benefit managers are looking to take their legal back-and-forth with the Federal Trade Commission to the 8th Circuit Court, according to a court filing issued late last week ...

Pharmacy benefits managers, or PBMs, are meant to lower drug prices by acting as a middleman between drug manufacturers and ...

My 19-year-old daughter required a treatment prescribed by her doctor. Even with my professional expertise, her doctor and I ...

Pharmacy benefit managers negotiate pricing and conditions for access to drugs, process prescription claims and manage retail ...

The Federal Trade Commission’s legal action against the three largest pharmacy benefit managers will move forward after a federal judge rejected their bid to halt the case. In a court filing ...

The U.S. House is renewing a push to take on pharmacy benefit managers that play an important role in the cost of ...

This system has come under scrutiny from the Federal Trade Commission, which in a July 2024 report called pharmacy benefit managers “the powerful middlemen inflating drug costs and squeezing ...